Videos

Vibeke Strand, MD, on Immunogenicity in Immune-Mediated Inflammatory Diseases

12/26/2019

In this video, Vibeke Strand, MD, discusses immunogenicity and its contributing factors among individuals with immune-mediated inflammatory diseases, the role of therapeutic drug monitoring in a rheumatology setting, and more.

Vibeke Strand, MD, is a clinical rheumatologist in California, as well as a biopharmaceutical consultant.

Published in partnership with

Stay in the Know

Rheumatology & Arthritis Newsletter

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1

Popular Articles

Transcript: How Should Rheumatologists Decide Which COVID-19 Informational Resources to Give Their Patients?

11/12/2010

Garret Duron: I think that’s a great question, and the same criteria would essentially apply in terms of looking at resources for patients. The question becomes slightly different, but it’s similar in terms of the relevancy, accessibility,...

Garret Duron: I think that’s a...

11/12/2010

Rheumatology & Arthritis

Clinical Update

Michelle Petri, MD, on Preventing and Managing SLE Flares

06/22/2011

Rheumatology & Arthritis

News

Knowledge, Trust Improve Shared Decision-Making for PsA Medication

08/06/2011

Active collaboration with clinicians helps patients feel less overwhelmed and more in control of their care, research shows.

Active collaboration with...

08/06/2011

Rheumatology & Arthritis

Vibeke Strand, MD, on Immunogenicity in Immune-Mediated Inflammatory Diseases

Stay in the Know

Partner Spotlight

Popular Articles

Specialties

Events

Year Round Education

HMP Global Products